16 results on '"Arsov C"'
Search Results
2. Worry about prostate cancer and risk perception among middle-aged men: Results from the PROBASE trial
3. Complications of primary open or robotic RetroPeritoneal Lymph Node Dissection (RPLND) in stage II A/B patients with seminoma – results from the prospective phase II PRIMETEST trial
4. A0815 - MRI-guided active surveillance without re-biopsy in patients with ISUP 1 and 2 prostate cancer – results of radical prostatectomy and mid-term follow up of the prospective PROMM-AS study.
5. A0960 - MRI-guided Active Surveillance without annual re-biopsy in patients with ISUP 1 and 2 prostate cancer – The prospective PROMM-AS Study.
6. P239 - Worry about prostate cancer and risk perception among middle-aged men: Results from the PROBASE trial.
7. A0899 - Digital Rectal Examination (DRE) is not useful as a solitary screening tool for prostate cancer in young men – Results from the PROBASE trial.
8. A0558 - Complications of primary open or robotic RetroPeritoneal Lymph Node Dissection (RPLND) in stage II A/B patients with seminoma – results from the prospective phase II PRIMETEST trial.
9. Risk-adjusted Screening for Prostate Cancer-Defining the Low-risk Group by Data from the PROBASE Trial.
10. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial.
11. Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST).
12. Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators.
13. Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies.
14. Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men: the PROBASE trial.
15. Words of wisdom: Re: Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study.
16. Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programme.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.